Levodopa minimum plasma concentration ( Cmin ) for each levodopa/carbidopa dose and for the mean of all levodopa/carbidopa doses increased substantially with all active treatments ( entacapone and opicapone ) when compared to the control group ( placebo ) , with values ranging from @-fold ( @ mg entacapone ) to @-fold ( @ mg opicapone ) .